ADHD and substance use disorders: developmental aspects and the impact of stimulant treatment
- PMID: 17453602
- DOI: 10.1080/10550490601082734
ADHD and substance use disorders: developmental aspects and the impact of stimulant treatment
Abstract
Adolescents and adults with substance use disorders often demonstrate symptoms of inattention, impulsivity, and hyperactivity. These core symptoms of ADHD may contribute to the development of substance use disorders by promoting antisocial behavior and substance use; conversely, substance use itself can adversely affect these symptoms. Common deficits in self-regulatory processes could underlie the developmental progression of these disorders, deficits further worsened by ongoing substance use. Some investigators have questioned whether stimulant treatment itself could promote substance abuse, while others have argued that such treatment reduces substance abuse. With an increased awareness of the phenomenon of adult ADHD and its relevance to substance-abusing persons, there is an increased awareness of the potential benefit of ADHD treatment on substance abuse treatment outcome. Consideration of an individual's developmental relationship between attention deficit/hyperactivity symptoms and substance use can inform treatment planning among patients seeking substance abuse treatment.
Similar articles
-
A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908x280707. Epub 2008 Apr 1. Curr Med Res Opin. 2008. PMID: 18384709 Review.
-
Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.J Clin Psychiatry. 2007;68 Suppl 11:15-22. J Clin Psychiatry. 2007. PMID: 18307377 Review.
-
ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.Addict Behav. 2014 Jan;39(1):325-8. doi: 10.1016/j.addbeh.2013.09.002. Epub 2013 Sep 10. Addict Behav. 2014. PMID: 24090624
-
Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.J Clin Psychiatry. 2003;64 Suppl 11:3-8. J Clin Psychiatry. 2003. PMID: 14529323
-
Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study.Am J Psychiatry. 2008 May;165(5):597-603. doi: 10.1176/appi.ajp.2007.07091486. Epub 2008 Mar 3. Am J Psychiatry. 2008. PMID: 18316421
Cited by
-
Unidirectional relationship between heroin self-administration and impulsive decision-making in rats.Psychopharmacology (Berl). 2012 Jan;219(2):443-52. doi: 10.1007/s00213-011-2444-8. Epub 2011 Sep 2. Psychopharmacology (Berl). 2012. PMID: 21887498 Free PMC article.
-
Cognitive impairment in cocaine users is drug-induced but partially reversible: evidence from a longitudinal study.Neuropsychopharmacology. 2014 Aug;39(9):2200-10. doi: 10.1038/npp.2014.71. Epub 2014 Mar 21. Neuropsychopharmacology. 2014. PMID: 24651468 Free PMC article.
-
Do executive function deficits predict later substance use disorders among adolescents and young adults?J Am Acad Child Adolesc Psychiatry. 2011 Feb;50(2):141-9. doi: 10.1016/j.jaac.2010.11.010. Epub 2011 Jan 6. J Am Acad Child Adolesc Psychiatry. 2011. PMID: 21241951 Free PMC article.
-
Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. CNS Drugs. 2009. PMID: 19621975 Review.
-
Familial, social, and individual factors contributing to risk for adolescent substance use.J Addict. 2013;2013:579310. doi: 10.1155/2013/579310. Epub 2013 Mar 20. J Addict. 2013. PMID: 24826363 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical